Summary by Futu AI
On September 6, 2024, Meeshanthini Dogan, the Chief Executive Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed a purchase of company stock. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Dogan's direct holdings in the company increased to a total of 1,655,429 shares. The purchase, conducted on the open market, reflects the CEO's direct investment in the company's stock and is a matter of record for investors monitoring insider activity.